Insider · CIK 0001192212
Chambon Philippe O.
Reports to the SEC for 15 companies · NEW YORK, NY
Transactions
50
Companies
15
Filings
15
CIK
0001192212
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2013-03-29 | NxStage Medical, Inc.A Award | — |
| 2013-03-12 | EPOCRATES INCNon-Qualified Stock Option (right to buy)D Disposition to Issuer | — |
| 2013-03-12 | EPOCRATES INCNon-Qualfied Stock Option (right to buy)D Disposition to Issuer | — |
| 2013-03-12 | EPOCRATES INCNon-Qualified Stock Option (right to buy)D Disposition to Issuer | — |
| 2013-03-12 | EPOCRATES INCNon-Qualified Stock Option (right to buy)D Disposition to Issuer | — |
| 2013-03-12 | EPOCRATES INCD Disposition to Issuer | — |
| 2012-12-31 | NxStage Medical, Inc.A Award | — |
| 2012-09-28 | NxStage Medical, Inc.A Award | — |
| 2012-08-13 | EPOCRATES INCNon-Qualified Stock Option (right to buy)A Award | — |
| 2012-06-29 | NxStage Medical, Inc.A Award | — |
| 2012-05-29 | NxStage Medical, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2012-05-29 | NxStage Medical, Inc.M Exercise/Conversion | +$29.8K |
| 2012-05-24 | NxStage Medical, Inc.Stock Option (right to buy)A Award | — |
| 2012-03-30 | NxStage Medical, Inc.A Award | — |
| 2012-03-16 | NxStage Medical, Inc.S Sale | −$1.43M |
| 2012-03-05 | NxStage Medical, Inc.S Sale | −$426K |
| 2012-01-09 | NxStage Medical, Inc.J Other | −$15.4M |
| 2011-12-30 | NxStage Medical, Inc.A Award | — |
| 2011-09-30 | NxStage Medical, Inc.A Award | — |
| 2011-09-14 | NxStage Medical, Inc.S Sale | −$374K |
| 2011-09-08 | NxStage Medical, Inc.S Sale | −$978K |
| 2011-09-01 | NxStage Medical, Inc.X Exercise of In-Money | +$621K |
| 2011-09-01 | NxStage Medical, Inc.S Sale | −$621K |
| 2011-09-01 | NxStage Medical, Inc.Warrants (right to buy)X Exercise of In-Money | — |
| 2011-09-01 | NxStage Medical, Inc.S Sale | −$38.6K |
| 2011-08-31 | NxStage Medical, Inc.S Sale | −$1.06M |
| 2011-08-16 | NxStage Medical, Inc.J Other | −$20.2M |
| 2011-06-30 | NxStage Medical, Inc.A Award | — |
| 2011-05-26 | NxStage Medical, Inc.M Exercise/Conversion | +$152K |
| 2011-05-26 | NxStage Medical, Inc.Stock Option (right to buy)A Award | — |
| 2011-05-26 | NxStage Medical, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2011-05-26 | NxStage Medical, Inc.F Tax Payment | −$152K |
| 2011-05-23 | AUXILIUM PHARMACEUTICALS INCJ Other | −$473K |
| 2011-05-11 | AUXILIUM PHARMACEUTICALS INCJ Other | −$16.5M |
| 2011-05-06 | EPOCRATES INCNon-Qualified Stock Option (right to buy)A Award | +$259K |
| 2011-03-31 | AUXILIUM PHARMACEUTICALS INCA Award | +$15K |
| 2011-03-31 | NxStage Medical, Inc.A Award | — |
| 2011-03-31 | AUXILIUM PHARMACEUTICALS INCA Award | +$3,735.78 |
| 2011-03-08 | AUXILIUM PHARMACEUTICALS INCJ Other | −$16.4M |
| 2011-02-07 | EPOCRATES INCC Conversion | — |
| 2011-02-07 | EPOCRATES INCC Conversion | — |
| 2011-02-07 | EPOCRATES INCS Sale | −$9.14M |
| 2011-02-07 | EPOCRATES INCSeries B Convertible Preferred StockC Conversion | — |
| 2011-02-07 | EPOCRATES INCSeries C Convertible Preferred StockC Conversion | — |
| 2011-01-26 | NxStage Medical, Inc.J Other | −$19.6M |
| 2010-12-31 | NxStage Medical, Inc.A Award | — |
| 2010-12-31 | AUXILIUM PHARMACEUTICALS INCA Award | +$15K |
| 2010-12-09 | NxStage Medical, Inc.S Sale | −$6,752.7 |
| 2010-12-08 | NxStage Medical, Inc.S Sale | −$604K |
| 2010-12-07 | NxStage Medical, Inc.S Sale | −$3.92M |
Recent filings
- 4NxStage Medical, Inc.0001012975-13-000131SEC(opens sec.gov)
- 4EPOCRATES INC0001096738-13-000022SEC(opens sec.gov)
- 4NxStage Medical, Inc.0001012975-13-000012SEC(opens sec.gov)
- 4NxStage Medical, Inc.0001012975-12-000271SEC(opens sec.gov)
- 4EPOCRATES INC0001096738-12-000019SEC(opens sec.gov)
- 4NxStage Medical, Inc.0001012975-12-000221SEC(opens sec.gov)
- 4NxStage Medical, Inc.0001012975-12-000160SEC(opens sec.gov)
- 4NxStage Medical, Inc.0001209191-12-030793SEC(opens sec.gov)
- 4NxStage Medical, Inc.0001209191-12-021454SEC(opens sec.gov)
- 4NxStage Medical, Inc.0001012975-12-000082SEC(opens sec.gov)
- 4NxStage Medical, Inc.0001012975-12-000046SEC(opens sec.gov)
- 4NxStage Medical, Inc.0001012975-12-000002SEC(opens sec.gov)
- 4NxStage Medical, Inc.0001209191-12-000633SEC(opens sec.gov)
- 4NxStage Medical, Inc.0001209191-11-050309SEC(opens sec.gov)
- 4NxStage Medical, Inc.0001012975-11-000263SEC(opens sec.gov)
Companies
- Aravive, Inc.10% Owner
- AUXILIUM PHARMACEUTICALS INCDirector
- CHIMERIX INC10% Owner
- CONCERT PHARMACEUTICALS, INC.10% Owner
- Durata Therapeutics, Inc.10% Owner
- EPOCRATES INCDirector, 10% Owner
- ICAGEN INCMember of 10% owner group
- iRhythm Holdings, Inc.10% OwnerIRTC
- Lite Strategy, Inc.10% OwnerLITS
- NxStage Medical, Inc.Director
- Oruka Therapeutics, Inc.DirectorORKA
- Oxford Immunotec Global PLCFormer 10% Beneficial Owner
- Paratek Pharmaceuticals, Inc.Former 10% Beneficial Owner
- Relypsa IncFormer 10% beneficial owner
- WORLD HEART CORP10% Owner
Address
C/O NEW LEAF VENTURE MGMT I, L.L.C. TIMES SQUARE TWR, 7 TIMES SQ, SUITE 1603
NEW YORK, NY, 10036